Copper(II)‐ and gold(III)‐mediated cyclization of a thiourea to a substituted 2‐aminobenzothiazole

Benzothiazole derivatives are a class of privileged molecules due to their biological activity and pharmaceutical applications. One route to these molecules is via intramolecular cyclization of thioureas to form substituted 2‐aminobenzothiazoles, but this often requires harsh conditions or employs expensive metal catalysts. Herein, the copper(II)‐ and gold(III)‐mediated cyclizations of thioureas to substituted 2‐aminobenzothiazoles are reported. The single‐crystal X‐ray structures of the thiourea N‐(3‐methoxyphenyl)‐N ′‐(pyridin‐2‐yl)thiourea, C₁₃H₁₃N₃OS, and the intermediate metal complexes aquabis[5‐methoxy‐N‐(pyridin‐2‐yl‐κN )‐1,3‐benzothiazol‐2‐amine‐κN ³]copper(II) dinitrate, [Cu(C₁₃H₁₁N₃OS)₂(H₂O)](NO₃)₂, and bis{2‐[(5‐methoxy‐1,3‐benzothiazol‐2‐yl)amino]pyridin‐1‐ium} dichloridogold(I) chloride monohydrate, (C₁₃H₁₂N₃OS)₂[AuCl₂]Cl·H₂O, are reported. The copper complex exhibits a distorted trigonal–bipyramidal geometry, with direct metal‐to‐benzothiazole‐ligand coordination, while the gold complex is a salt containing the protonated uncoordinated benzothiazole, and offers evidence that metal reduction (in this case, Au^III to Au^I) is required for the cyclization to proceed. As such, this study provides further mechanistic insight into the role of the metal cations in these transformations.